[ASAP] Discovery of ARD-2051 as a Potent and Orally Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer

Journal of Medicinal ChemistryDOI: 10.1021/acs.jmedchem.3c00405
Source: Journal of Medicinal Chemistry - Category: Chemistry Authors: Source Type: research